HIV and pandemic influenza virus: Two great infectious disease challenges

被引：5

作者：

Ada, G ^{[1
]}

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Div Cell Biol & Immunol, Canberra, ACT 2601, Australia

来源：

VIROLOGY | 2000年 / 268卷 / 02期

关键词：

D O I：

10.1006/viro.2000.0207

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页码：227 / 230

页数：4

共 6 条

[1]

ADA G, 1997, VACCINES VACCINATION

[2] Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus [J].

Kent, SJ ;

Zhao, A ;

Best, SJ ;

Chandler, JD ;

Boyle, DB ;

Ramshaw, IA .

JOURNAL OF VIROLOGY, 1998, 72 (12) :10180-10188

[3] The economic impact of pandemic influenza in the United States: Priorities for intervention [J].

Meltzer, MI ;

Cox, NJ ;

Fukuda, K .

EMERGING INFECTIOUS DISEASES, 1999, 5 (05) :659-671

[4] A universal influenza A vaccine based on the extracellular domain of the M2 protein [J].

Neirynck, S ;

Deroo, T ;

Saelens, X ;

Vanlandschoot, P ;

Jou, WM ;

Fiers, W .

NATURE MEDICINE, 1999, 5 (10) :1157-1163

[5] VACCINATION TO PREVENT PERSISTENT VIRAL-INFECTION [J].

OLDSTONE, MBA ;

TISHON, A ;

EDDLESTON, M ;

DELATORRE, JC ;

MCKEE, T ;

WHITTON, JL .

JOURNAL OF VIROLOGY, 1993, 67 (07) :4372-4378

[6] Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations [J].

Robinson, HL ;

Montefiori, DC ;

Johnson, RP ;

Manson, KH ;

Kalish, ML ;

Lifson, JD ;

Rizvi, TA ;

Lu, S ;

Hu, SL ;

Mazzara, GP ;

Panicali, DL ;

Herndon, JG ;

Glickman, R ;

Candido, MA ;

Lydy, SL ;

Wyand, MS ;

McClure, HM .

NATURE MEDICINE, 1999, 5 (05) :526-534

← 1 →